Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Paptizer 360

K-Number: K252471 · 2026-04-29

Decision Date2026-04-29
Product CodeQXQ
Advisory CommitteeHO
DecisionSubstantially Equivalent

Device Summary

Paptizer 360 is a medical device manufactured by LiViliti Health Products Corporation. It received FDA 510(k) clearance on 2026-04-29 under approval number K252471. The device is classified under product code QXQ. It was reviewed by the HO advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Paptizer 360?

Paptizer 360 is a medical device that received FDA 510(k) clearance on 2026-04-29. It is manufactured by LiViliti Health Products Corporation. The 510(k) number is K252471.

When was Paptizer 360 approved by the FDA?

Paptizer 360 received FDA 510(k) clearance on 2026-04-29, under approval number K252471.

What company makes Paptizer 360?

Paptizer 360 is manufactured by LiViliti Health Products Corporation.

What is the FDA product code for Paptizer 360?

The FDA product code for Paptizer 360 is QXQ.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.